Upside case
Bull case
$49+313.4%
JBS would need investors to value it at roughly 7x earnings — about 5x more generous than today's 2x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Analysis OverviewBuyUpdated Jun 18, 2026
JBS N.V. (JBS) Stock Analysis
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Analyst consensus
Buy
Covering
3
analysts
2 bullish · 0 bearish · 3 covering JBS
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
Consensus Target
$20
+67.6% vs today
Scenario Range
$24 – $49
Model bear to bull value window
Coverage
3
Published analyst ratings
Valuation Context
1.6x
Forward P/E · Market cap $26.5B
JBS price targets
Three scenarios for where JBS stock could go
Current
~$12
Confidence
42 / 100
Updated
Jun 18, 2026
Where we are now
Current · $12
Bear
$24
Base
$37
Bull
$49
Market caseClosest to today
Base case
$37+213.7%
At 5x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
Stress case
Bear case
$24+97.7%
The bear case assumes sentiment or fundamentals disappoint enough to push JBS down roughly 98% from the current price.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.
JBS N.V.
JBS · NYSEConsumer DefensivePackaged FoodsDecember year-end
JBS is one of the world's largest protein processors, operating as a vertically integrated meat company that slaughters, processes, and distributes beef, pork, chicken, and prepared foods globally. It generates revenue primarily from meat sales—with beef (~45%), chicken (~30%), and pork (~15%) as its main segments—alongside value-added prepared foods and byproducts like leather and biodiesel. The company's competitive advantage lies in its massive scale, vertical integration across the supply chain, and global footprint that creates cost efficiencies and market access.
Market Cap
$26.5B
Revenue TTM
$477.3B
Net Income TTM
$9.5B
Net Margin
2.0%
JBS Revenue and Earnings Performance
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
EPS Beat Rate
27%Exceptional
12 quarters tracked
Revenue Beat Rate
27%Exceptional
vs consensus estimates
Avg EPS Surprise
-31.3%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Last 4 Quarters
EPS beats: 2 of 4Q3 2025
EPS
$0.53/$0.51
Revenue
$21.9B/$22.0B
Q4 2025
EPS
$0.52/$0.51
Revenue
$22.6B/$22.0B
Q1 2026
EPS
$0.39/$2.26
Revenue
$23.1B/$119.5B
Q2 2026
EPS
$0.20/$0.20
Revenue
$21.6B/$21.7B
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.53/$0.51 | +4.5% | $21.9B/$22.0B | -0.2% |
| Q4 2025 | $0.52/$0.51 | +2.6% | $22.6B/$22.0B | +2.9% |
| Q1 2026 | $0.39/$2.26 | -82.7% | $23.1B/$119.5B | -80.7% |
| Q2 2026 | $0.20/$0.20 | -2.2% | $21.6B/$21.7B | -0.2% |
FY1–FY2 Estimates
Revenue Outlook
FY1
$520.2B
+9.0% YoY
FY2
$556.9B
+7.1% YoY
EPS Outlook
FY1
$4.32
-51.2% YoY
FY2
$4.68
+8.3% YoY
Trailing FCF (TTM)-$64M
FCF Margin: -0.0%
Next Earnings
August 10, 2026
Expected EPS
$0.30
Expected Revenue
$22.8B
JBS beat EPS estimates in 2 of 4 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.
JBS Revenue Breakdown by Segment
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest disclosure
FY 2025
Total disclosed revenue $39.3B
Product Mix
Latest annual revenue by segment or product family
Segment breakdown not available for this company.
Geographic Mix
Latest annual revenue by reported region
South America
63.1%
YoY unavailable
Tap, hover, or focus a slice to inspect segment detail.
South America is the largest reported region at 63.1%, with no year-over-year comparison yet.
JBS Valuation Snapshot
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Relative Value Signal
Cheap versus peers
Fair value est. $155 — implies +1199.9% from today's price.
Upside to Fair Value
1199.9%
potential upside
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
JBS
5.9x
vs
S&P 500
24.4x
76% discount
vs Consumer Defensive Trailing P/E
JBS
5.9x
vs
Consumer Defensive
18.9x
69% discount
vs JBS 5Y Avg P/E
Today
5.9x
vs
5Y Average
1.4x
+324% premium
Forward PE
1.6x
S&P 500
18.8x
-91%
Consumer Defensive
14.2x
-89%
5Y Avg
—
—
Trailing PE
5.9x
S&P 500
24.4x
-76%
Consumer Defensive
18.9x
-69%
5Y Avg
1.4x
+324%
PEG Ratio
0.14x
S&P 500
1.66x
-92%
Consumer Defensive
1.92x
-93%
5Y Avg
—
—
EV/EBITDA
6.7x
S&P 500
15.2x
-56%
Consumer Defensive
11.1x
-40%
5Y Avg
3.3x
+104%
Price/FCF
32.8x
S&P 500
20.7x
+59%
Consumer Defensive
15.3x
+115%
5Y Avg
3.7x
+779%
Price/Sales
0.3x
S&P 500
3.1x
-91%
Consumer Defensive
0.9x
-67%
5Y Avg
0.0x
+779%
Dividend Yield
13.50%
S&P 500
1.91%
+605%
Consumer Defensive
3.06%
+341%
5Y Avg
—
—
| Metric | JBS | S&P 500 | Consumer Defensive | 5Y Avg JBS |
|---|---|---|---|---|
| Forward PE | 1.6x | 18.8x-91% | 14.2x-89% | — |
| Trailing PE | 5.9x | 24.4x-76% | 18.9x-69% | 1.4x+324% |
| PEG Ratio | 0.14x | 1.66x-92% | 1.92x-93% | — |
| EV/EBITDA | 6.7x | 15.2x-56% | 11.1x-40% | 3.3x+104% |
| Price/FCF | 32.8x | 20.7x+59% | 15.3x+115% | 3.7x+779% |
| Price/Sales | 0.3x | 3.1x-91% | 0.9x-67% | 0.0x+779% |
| Dividend Yield | 13.50% | 1.91% | 3.06% | — |
JBS trades above S&P 500 benchmarks on 1 of 6 measured multiples — appears modestly priced relative to the S&P 500 on most measures.
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolJBS Financial Health
Verdict
Adequate
JBS 11.2% ROIC signals a durable competitive advantage — returns 15.9% of market cap to shareholders annually.
Cash Engine
Revenue, margins, and cash generation
Revenue (TTM)
Trailing-twelve-month sales base
$477.3B
Revenue Growth
TTM vs prior year
+8.0%
Gross Margin
Gross profit as a share of revenue
12.3%
Operating Margin
Operating income divided by revenue
4.3%
Net Margin
Net income divided by revenue
2.0%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$8.86
Free Cash Flow (TTM)
Cash generation after capex
-$64M
FCF Margin
FCF as share of revenue — the primary cash quality signal
-0.0%
Capital Quality
ROIC, leverage, and debt serviceability
ROIC
Return on invested capital — primary competitive quality signal
11.2%
ROA
Return on assets, trailing twelve months
5.1%
Cash & Equivalents
Liquid assets on the balance sheet
$25.1B
Net Debt
Total debt minus cash
$100.6B
Debt Serviceability
Net debt as a multiple of annual free cash flow
—
ROE
Return on equity, trailing twelve months
24.0%
Shareholder Returns
How capital is returned to owners
Total shareholder yield
15.9%
Dividend
13.5%
Buyback
2.4%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$3.2B
Dividend / Share
Annualized trailing dividend per share
$8.24
Payout Ratio
Share of earnings distributed as dividends
79.4%
Shares Outstanding
Declining as buybacks retire shares
2.2B
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageJBS Stock Risk Factors
Key factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
High Risk
Operational risks
JBS operates in multiple global markets, exposing it to geopolitical, regulatory, and supply chain complexities.
High Risk
Earnings volatility
As a major processor of beef, pork, and poultry, JBS is highly susceptible to commodity price fluctuations and input cost pressures.
Medium
Regulatory scrutiny
Being a large player in the food industry, JBS faces heightened regulatory risks across different jurisdictions.
Medium
Competitive pressures
JBS operates in a highly competitive industry with thin margins, facing rivals in beef, pork, and poultry processing.
Lower
Valuation concerns
Despite bullish analyst ratings, the stock's undervaluation suggests market skepticism or overlooked risks.
High Risk
Risk factor volume
JBS disclosed 49 risk factors in its recent earnings report, indicating a high level of operational and financial challenges.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Why JBS Stock Could Outperform
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
Global market leadership
JBS is a leading global food company with extensive operations in multiple countries, positioning it as a key player in the protein sector.
Strong financial metrics
JBS's trailing P/E of 15.53 and forward P/E of 3.87 indicate strong earnings potential and attractive valuation.
Growth through acquisitions
JBS recently agreed to invest $150 million for an 80% stake in a food business in Oman, showcasing its expansion strategy.
Diversified protein portfolio
The company operates across beef, pork, poultry, and plant-based products, reducing reliance on any single market segment.
Innovation focus
JBS emphasizes innovation in its operations, driving growth and efficiency in the competitive food industry.
Industry dominance
JBS is the second-largest processor of beef and pork in the U.S. and owns Pilgrim's, the second-largest poultry company.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
JBS Stock Price Performance
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Current Price
$11.93
52W Range Position
6%
52-Week Range
Current price plotted between the 52-week low and high.
52-Week Low
$11.49
+3.8% from the low
52-Week High
$18.65
-36.0% from the high
1 Month
-7.23%
3 Month
-20.09%
YTD
-15.9%
1 Year
-12.7%
3Y CAGR
-4.9%
5Y CAGR
-3.0%
10Y CAGR
-1.5%
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
JBS vs Peers
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
Peer Set
Accurate peer set
Forward PE
1.6x
vs 13.7x median
-88% below peer median
Revenue Growth
+9.0%
vs +4.0% median
+125% above peer median
Net Margin
2.0%
vs 4.8% median
-58% below peer median
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
JBS JBS JBS N.V. | $26.5B | 1.6x | +9.0% | 2.0% | Buy | +67.6% |
TSN TSN Tyson Foods, Inc. | $19.7B | 13.7x | +4.0% | 0.8% | Buy | +34.3% |
HRL HRL Hormel Foods Corporation | $13.3B | 16.3x | +2.1% | 3.8% | Hold | -2.7% |
PPC PPC Pilgrim's Pride Corporation | $6.5B | 8.1x | +5.4% | 4.8% | Hold | +36.6% |
WH WH Wyndham Hotels & Resorts, Inc. | $6.3B | 17.6x | +1.6% | 13.4% | Buy | +15.8% |
SFD SFD Smithfield Foods, Inc. | $9.8B | 9.4x | +9.0% | 6.5% | Buy | +28.3% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
JBS Dividend and Capital Return
JBS returns 15.9% total yield, led by a 13.50% dividend. Buybacks add another 2.4%.
Dividend WatchFCF Unknown
Total Shareholder Yield
15.9%
Dividend + buyback return per year
Buyback Yield
2.4%
Dividend Yield
13.50%
Payout Ratio
79.4%
How JBS Splits Its Return
Div 13.50%
Dividend 13.50%Buybacks 2.4%
Dividend Profile
Yield, cadence, and growth quality
Dividend / Share
Trailing annualized cash dividend
$8.24
Growth Streak
Consecutive years of dividend increases
2Y
3Y Div CAGR
12.1%
5Y Div CAGR
45.1%
Ex-Dividend Date
—
Payment Cadence
Annual
1 payments over the last 12 months
Buyback Engine
How much per-share support comes from repurchases
Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$3.2B
Estimated Shares Retired
268M
Approx. Share Reduction
12.1%
Shares Outstanding
Current diluted share count from the screening snapshot
2.2B
At 12.1%/year, buybacks mechanically lift EPS even with flat earnings — each remaining share represents a slightly larger piece of the company.
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $1.00 | — | — | — |
| 2025 | $1.06 | +3.3% | 20.7% | 77.9% |
| 2024 | $1.02 | +162.0% | — | — |
| 2023 | $0.39 | -47.9% | — | — |
| 2022 | $0.75 | -28.3% | — | — |
FAQ
7 questionsJBS Investor Questions
Common questions answered from live analyst data and company financials.
01Is JBS N.V. (JBS) stock a buy or sell in 2026?
JBS N.V. (JBS) is rated Buy by Wall Street analysts as of 2026. Of 3 analysts covering the stock, 2 rate it Buy or Strong Buy, 1 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $20, implying +67.6% from the current price of $12. The bear case scenario is $24 and the bull case is $49.
02What is the JBS stock price target for 2026?
The Wall Street consensus price target for JBS is $20 based on 3 analyst estimates. The high-end target is $23 (+92.8% from today), and the low-end target is $17 (+42.5%). The base case model target is $37.
03Is JBS N.V. (JBS) stock overvalued in 2026?
JBS trades at 1.6x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals cheap versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
04What are the main risks for JBS N.V. (JBS) stock in 2026?
The primary risks for JBS in 2026 are: (1) Operational risks — JBS operates in multiple global markets, exposing it to geopolitical, regulatory, and supply chain complexities. (2) Earnings volatility — As a major processor of beef, pork, and poultry, JBS is highly susceptible to commodity price fluctuations and input cost pressures. (3) Risk factor volume — JBS disclosed 49 risk factors in its recent earnings report, indicating a high level of operational and financial challenges. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
05What is JBS N.V.'s revenue and earnings forecast?
Analyst consensus estimates JBS will report consensus revenue of $520.2B (+9.0% year-over-year) and EPS of $4.32 (-51.2% year-over-year) for the upcoming fiscal year. The following year, analysts project $556.9B in revenue.
06When does JBS N.V. (JBS) report its next earnings?
JBS N.V. is expected to report its next earnings on approximately 2026-08-10. Consensus expects EPS of $0.30 and revenue of $22.8B. Over recent quarters, JBS has beaten EPS estimates 27% of the time.
07How much free cash flow does JBS N.V. generate?
JBS N.V. (JBS) had a free cash outflow of $64M in free cash flow over the trailing twelve months — a free cash flow margin of 0.0%. JBS returns capital to shareholders through dividends (13.5% yield) and share repurchases ($3.2B TTM).